McKesson Corp
mckesson.comMcKesson Corp (NYSE: MCK) is a healthcare distribution company that distributes pharmaceuticals, medical supplies, and specialty drugs across North America. Revenue is transactional, generated primarily from the purchase and resale of pharmaceutical and medical-surgical products to healthcare providers, pharmacies, and health systems, supplemented by services including practice management, technology solutions, and group purchasing organizations. McKesson operates across several segments: North American Pharmaceutical distribution, Medical-Surgical Solutions, Oncology and Multispecialty services, and a Canadian retail pharmacy network of approximately 2,600 independent pharmacies operating under banners including IDA, Guardian, Remedy'sRx, Proxim, and Uniprix (as of the 10-K filed 2026-05-08). The Oncology and Multispecialty segment supports community-based specialists through the U.S. Oncology Network, one of the largest physician-led integrated oncology networks in the United States. Brian S. Tyler has served as Chief Executive Officer since April 2019. Britt J. Vitalone has served as Chief Financial Officer since January 2018.
Products & Services
Pharmaceutical distribution (branded and specialty); medical-surgical supply distribution; specialty drug distribution to oncology and other specialty practices; group purchasing organization services (Onmark); practice management and healthcare IT platforms; revenue cycle management; vaccine distribution; Canadian retail pharmacy operations under IDA, Guardian, Remedy'sRx, Proxim, and Uniprix banners; U.S. Oncology Network services.
Revenue Model
Transactional revenue from pharmaceutical and medical-surgical product distribution; supplemented by fee-based services including specialty drug distribution, group purchasing organizations (Onmark GPO), revenue cycle management, practice consulting, and healthcare technology solutions.
Customers & Markets
Community-based physician specialists including oncologists, rheumatologists, ophthalmologists, urologists, and neurologists; independent pharmacies; health systems; government entities; ambulatory care providers.
Geographic Exposure
Primary operations in the United States and Canada; non-U.S. operations expose the company to foreign currency exchange rate risk as noted in the FY2026 10-K.
Financial Snapshot
Loading...
